about
Spontaneous tumor incidence in rasH2 mice: review of internal data and published literature.Historical control data of spontaneous tumors in transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice.Nonclinical safety profile of telbivudine, a novel potent antiviral agent for treatment of hepatitis BSociety of Toxicologic Pathology position paper: organ weight recommendations for toxicology studies.Mouse skin models for carcinogenic hazard identification: utilities and challenges.An industry perspective on the utility of short-term carcinogenicity testing in transgenic mice in pharmaceutical development.Carcinogenicity assessments of biotechnology-derived pharmaceuticals: a review of approved molecules and best practice recommendations.A further review of inhalation studies with cigarette smoke and lung cancer in experimental animals, including transgenic mice.Opportunities for an alternative integrating testing strategy for carcinogen hazard assessment?Regulatory Forum commentary: alternative mouse models for future cancer risk assessment.Progression of Serosal Vascular Proliferative Lesions to Hemangiosarcomas in the Uterus of the 26-Week Tg.rasH2 Mice Carcinogenicity Studies.Identification of biomarkers of chemically induced hepatocarcinogenesis in rasH2 mice by toxicogenomic analysis.Hematopoietic proliferative lesions in the spleen of rasH2 transgenic mice treated with MNU.26-Week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice.Effect of oral gavage dosing regimens in female Tg rasH2 transgenic mice.The fate of 4-hydroxycarbazole metabolite: metabolism and carcinogenicity assessment of a β-adrenergic receptor modulator containing carbazole structure.The rasH2 mouse model for assessing carcinogenic potential of pharmaceuticals.N-Methyl-N-Nitrosourea (MNU): A positive control chemical for p53+/- mouse carcinogenicity studies.A 26-week carcinogenicity study of 2-amino-3-methylimidazo[4,5-f]quinoline in rasH2 mice.Scientific Opinion on the use of Resorcinol as a food additiveLung Tumor Induction by 26-week Dermal Application of 1,2-Dichloroethane in CB6F1-Tg rasH2 Mice.Reduction in the number of animals and the evaluation period for the positive control group in Tg.rasH2 short-term carcinogenicity studies.Genotoxic assessment and toxicity evaluation of peginesatide in CByB6F1 hybrid mice.Tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in an ultra-short-term skin carcinogenesis bioassay using rasH2 mice.Rapid induction of skin tumors in human but not mouse c-Ha-ras proto-oncogene transgenic mice by chemical carcinogenesis.
P2860
Q34157088-72FA935B-7FDE-4ED4-BC4A-14EBAEFBE474Q34549812-EC98EA47-0DEC-4581-AB1C-D640B616D9E7Q34591879-BAB0727E-4AF6-44B8-98BD-18E3338F0C95Q36938049-A49ED0B4-7E14-4A79-B7D8-FF3F91EF9091Q37039811-40A975DA-2189-49FE-B52B-1AE5096B2711Q37628343-E93EDA29-868C-43D5-A0D5-3B1348DD56C7Q37753534-5E2C383B-0074-4721-ADFE-720F346DCE96Q37779103-516B601B-E071-4090-8876-A95B0D395F01Q37964696-7C3AE368-05D8-410B-B71E-06156B9486B4Q39363493-B745A200-409B-4761-B2C2-A9F3420B4E54Q39578139-446D1DBE-1DD7-45BA-BDE9-2F8460EE6EB1Q42733623-25C54435-4EDF-4E37-87C7-D88E480EFA36Q42872518-0CC7593F-F386-42FE-93BF-BE4DCF276102Q43112569-86208681-D1C3-479E-885F-C2E100252540Q44942439-34D112E1-5F99-4513-8279-729BF4CF051AQ45252564-4EE51A2D-57D5-46C5-ABB1-136112131996Q46322348-2D65FC2E-D48A-4935-97FD-FBFCCFE26E98Q46338587-F4D13CB7-FB76-4647-B1A2-884ACA32E045Q46990423-C03B8EF1-FC92-4F80-A87B-7CCAD1B9AAFCQ47147812-3206BB81-D51D-4382-9A95-DE8A3F3B4053Q47789678-6C066698-2265-4C74-AB34-7B1AC8DABCA7Q48130096-065A86F0-4702-462E-9C73-6D7B698E4EE0Q50041581-CD58578E-B34E-4546-A02A-78A4B9C22D0EQ53255024-9986CAFC-FC77-4C97-86E0-BFF40A520219Q53344567-D2079B33-EC2D-4B54-A279-DF83AB56DA15
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The Tg rasH2 mouse in cancer hazard identification.
@ast
The Tg rasH2 mouse in cancer hazard identification.
@en
The Tg rasH2 mouse in cancer hazard identification.
@nl
type
label
The Tg rasH2 mouse in cancer hazard identification.
@ast
The Tg rasH2 mouse in cancer hazard identification.
@en
The Tg rasH2 mouse in cancer hazard identification.
@nl
prefLabel
The Tg rasH2 mouse in cancer hazard identification.
@ast
The Tg rasH2 mouse in cancer hazard identification.
@en
The Tg rasH2 mouse in cancer hazard identification.
@nl
P2093
P2860
P1476
The Tg rasH2 mouse in cancer hazard identification.
@en
P2093
Arthur J Roth
Carl L Alden
Daniel Morton
Toshimi Usui
P2860
P304
P356
10.1080/01926230252824851
P407
P577
2002-01-01T00:00:00Z